The Immune Assessment Laboratory assist investigators at Dana-Farber Cancer Institute, its partners and external sites in establishing mechanistic and biomarker endpoints for clinical studies. We provide data generation for clinical trials across multiple disease centers as well as the necessary expertise to design and develop assays related to cancer immunology biomarkers discovery. We are also involved in the collection of blood and solid tissue from patients participating in more than 50 clinical trials at DFCI as well as multiple external sites. Our Lab is equipped with the latest technologies for the detection of soluble biomarkers: Luminex and OLINK, as well as determining cellular phenotypes using mass cytometry (CyToF). We provide researchers with access to the latest innovations in immune monitoring in a GLP quality-controlled, HIPAA compliant setting.

The IAL is an integral member of an NIH Cancer Moonshot initiative, CIMAC (Cancer Immune Monitoring and Analysis Center), providing mass cytometry expertise to NCI clinical trials nationwide.

Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong.  As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff.  Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.

• Bachelor's degree required in Biology or healthcare related science preferred
• Sterile technique and pipetting knowledge are required
• Blood handling, and immune cells isolation and purification related techniques is a plus
• Knowledge of computational data analysis basics is a plus
• The successful candidate is a team-oriented with exceptional organizational skills
• Understands lab etiquette and participate in general laboratory responsibilities
• Must be detail-oriented and strictly adhere to clinical SOPs

 Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.